NUVB Reports $18.5M Q1 Revenue, $533.7M Cash, Adds Japan Safusidenib Rights, NCCN Guideline Inclusion
Nuvation Bio Inc. · PHARMACEUTICAL PREPARATIONS · Now $4.96
+9.5% in 1d after detection
Post-detection moves
1h
—
1d
+9.5%
3d
+9.1%
7d
+8.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS